Study: Pre-dementia use of Alzheimer's drugs doesn't stall disease onset

11/27/2007 | Yahoo!

Alzheimer's disease treatments, such as Aricept, Reminyl and Exelon, appear to be ineffective in delaying the progression from mild cognitive impairment to dementia, Italian scientists report. The findings contradict a popular thought among experts and patients groups that anti-cholinesterase drugs should be made available to MCI patients.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA